BP p.l.c. (NYSE:BP) reportedly plans to assess expanding and diversifying its biofuel operations in Brazil, exploring new products like second-generation ethanol and sustainable aviation fuel following its acquisition of a stake in BP Bunge Bioenergia.
Last week, the British oil major bought Bunge Global SA's (NYSE:BG) 50% stake in their joint venture, BP Bunge Bioenergia S.A., for an enterprise value of about $1.4 billion.
The acquisition will consolidate 100% of the venture's financial results, including net debt of about $0.5 billion and lease obligations of around $0.7 billion.
In written comments, the company expressed its plans to utilize the expansive biofuel infrastructure of the venture in Brazil, including an industrial complex comprising 11 plants located across five states that specialize in processing sugarcane, reported Reuters.
BP said in the comment, "We will seek to explore new growth opportunities in the region and develop new bioenergy platforms, such as next-generation ethanol, SAF, e-fuels and biogas," per the report.
Biofuels expert Soren Jansen, a former executive at Brazil's Copersucar, stated, "The whole alcohol-to-jetfuel supply chain is very expensive to build up, and the deep pockets from the oil companies is accelerating the process with an initial geographic spread over Brazil, the U.S., Europe and Japan."
As per the report, the approach of BP mirrors that of Shell plc (NYSE:SHEL), which previously teamed up with Brazilian sugar and ethanol major Cosan S.A. (NYSE:CSAN) to form Raizen SA, which is pioneering the world's largest cellulosic ethanol program, focusing on second-generation ethanol.
Notably, Raizen launched its second 2G ethanol plant in May, producing fuel from biomass residues of processed sugarcane with 80% less carbon than gasoline.
Investors can gain exposure to the stock via Direxion Hydrogen ETF (ARCA: HJEN) and First Trust Exchange-Traded Fund IV FT Energy Income Partners Strategy ETF (ARCA: EIPX).
Price Action: BP shares are up 0.76% at $35.78 premarket at the last check Monday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
BP p.l.c.（NYSE：BP）计划评估在巴西扩大和多元化其生物燃料业务，探索新产品，如第二代乙醇和可持续航空燃料，其在收购BP Bunge Bioenergia的股份后，与该公司共同组建BP Bunge Bioenergia后，进行此次探索。
上周，这家英国石油巨头以约14亿美元的企业价值，购买了邦吉全球公司（NYSE：BG）持有的BP Bunge Bioenergia SA合资公司50%的股份。
该收购将整合该公司合资企业100%的财务结果，包括约5亿美元的净负债和约7亿美元的租赁义务。
据路透社报道，在书面评论中，该公司表示计划利用在巴西成立的生物燃料合资企业提供的广阔基础设施，其中包括由11家工厂组成的产业复合体，分布在五个州，专门加工甘蔗。
BP在评论中表示:"我们将寻求在该地区探索新的增长机遇，并开发新的生物能源平台，例如下一代乙醇，SAF，电力燃料和生物燃气"。
生物燃料专家Soren Jansen曾是巴西Copersucar的高管，他表示:"整个酒精-喷气燃料供应链非常昂贵，石油公司的深袋子正在加速巴西、美国、欧洲和日本等地区的进程。"
据报道，BP的做法与壳牌股份有限公司（NYSE：SHEL）相似，壳牌股份有限公司此前曾与巴西糖和乙醇重要生产商科桑公司（NYSE：CSAN）合作组建了雷森公司，雷森公司开创了世界上最大的纤维素乙醇项目，重点关注第二代乙醇。
值得注意的是，雷森公司于5月推出了第二个2G乙醇工厂，利用处理后的甘蔗生物质残留物生产燃料，碳排放量比汽油少80%。
投资者可以通过 Direxion Hydrogen ETF (ARCA: HJEN) 和 First Trust Exchange-Traded Fund IV FT Energy Income Partners Strategy ETF (ARCA: EIPX) 来获得这只股票的曝光。
股价表现：截至周一最后一次检查，BP股价在盘前上涨0.76％，报35.78美元。
免责声明：本文部分内容使用了Benzinga Neuro的帮助。此内容是通过AI工具部分制作的，并由Benzinga编辑进行了审查和发布。
